- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
E-Z-EM buys into virtual colonoscopy firm
The world’s largest manufacturer of contrast agents for gastrointestinal radiology has taken a 5% equity position in PointDx, an emerging medical technology company focused on the development of virtual colonoscopy software and structured reporting
The world’s largest manufacturer of contrast agents for gastrointestinal radiology has taken a 5% equity position in PointDx, an emerging medical technology company focused on the development of virtual colonoscopy software and structured reporting solutions for radiology. The deal also provides E-Z-EM with a three-year warrant to purchase an additional 120,000 shares and one seat on the PointDx board of directors. By taking an equity stake in PointDx, E-Z-EM hopes to follow and support the development of new applications in GI medicine.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
